Infective endocarditis resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(40 intermediate revisions by 5 users not shown)
Line 1: Line 1:
<div style="width: 80%;">
<div style="width: 80%;">
__NOTOC__
__NOTOC__
'''For infective endocarditis prevention resident survival guide click [[infective endocarditis prevention resident survival guide|here]].'''
{{CMG}}; {{AE}} {{FK}}; {{MM}}; {{Rim}}
{{CMG}}; {{AE}} {{FK}}; {{MM}}; {{Rim}}


Line 7: Line 9:
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align=center| {{fontcolor|#2B3B44|Infective endocarditis Resident Survival Guide Microchapters}}
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align=center| {{fontcolor|#2B3B44|Infective endocarditis Resident Survival Guide Microchapters}}
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ Endocarditis resident survival guide#Overview|Overview]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#Overview|Overview]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#Causes|Causes]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#FIRE:Focused Initial Rapid Evaluation|FIRE]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#Causes|Causes]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#Complete Diagnostic Approach|Diagnosis]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#FIRE:Focused Initial Rapid Evaluation|FIRE]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#Treatment|Treatment]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#Complete Diagnostic Approach|Diagnosis]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#Prophylaxis|Prophylaxis]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#Treatment|Treatment]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#Do's|Do's]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#Do's|Do's]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Endocarditis resident survival guide#Don'ts|Don'ts]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[{{PAGENAME}}#Don'ts|Don'ts]]
|}
|}


==Overview==
==Overview==
Infective endocarditis is the [[infection]] of the [[endothelium]] of the heart including but not limited to the valves. While acute bacterial endocarditis is caused by an infection with a virulent organism such as [[staphylococcus aureus]], group A or other [[beta-hemolytic streptococci]], subacute bacterial endocarditis is an indolent infection with less virulent organisms like [[streptococcus viridans]].  Patients with unexplained fever for more than 48 hours and who are at high risk for infective endocarditis and patients among whom valve regurgitation is newly diagnosed should undergo a diagnostic workup to rule out endocarditis.  The diagnosis of endocarditis depends on a thorough history and physical exam as well as on the results of blood cultures and [[TTE|transthoracic echocardiogram]].  The modified Duke criteria is used to establish the diagnosis of [[endocarditis]].  [[Endocarditis]] is initially treated with empiric antibiotic therapy until the causative agent is identified.<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref><ref name="Baddour-2005">{{Cite journal  | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>
Infective endocarditis is an [[infection]] in the [[endothelium]] of the heart, including but not limited to the [[valves]]. While ''acute'' bacterial endocarditis is caused by an infection with a virulent organism such as [[staphylococcus aureus]], group A or other [[beta-hemolytic streptococci]], ''subacute'' bacterial endocarditis is an indolent infection with less virulent organisms like [[streptococcus viridans]].  Patients with unexplained [[fever]] for more than 48 hours and who are at high risk for [[infective endocarditis]] and patients among whom [[valvular disease|valve regurgitation]] is newly diagnosed should undergo a diagnostic workup to rule out [[endocarditis]].  The diagnosis of endocarditis depends on a thorough history and physical exam as well as the results of blood cultures and the findings on [[TTE|transthoracic echocardiogram]] or [[TEE|transesophageal echocardiogram]].  The [[modified Duke criteria]] is used to establish the diagnosis of [[endocarditis]].  [[Endocarditis]] is initially treated with [[Endocarditis antimicrobial treatment|empiric antibiotic therapy]] until the causative agent is identified.<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref><ref name="Baddour-2005">{{Cite journal  | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>


==Causes==
==Causes==
Line 36: Line 36:
*[[Streptococcus viridans|Streptococcus viridans infection]]
*[[Streptococcus viridans|Streptococcus viridans infection]]


==FIRE:Focused Initial Rapid Evaluation==
==FIRE: Focused Initial Rapid Evaluation==
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref><ref name="pmid3516105">{{cite journal| author=Weinstein L| title=Life-threatening complications of infective endocarditis and their management. | journal=Arch Intern Med | year= 1986 | volume= 146 | issue= 5 | pages= 953-7 | pmid=3516105 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3516105  }} </ref>
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref><ref name="pmid3516105">{{cite journal| author=Weinstein L| title=Life-threatening complications of infective endocarditis and their management. | journal=Arch Intern Med | year= 1986 | volume= 146 | issue= 5 | pages= 953-7 | pmid=3516105 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3516105  }} </ref>


<span style="font-size:85%">Boxes in red signify that an urgent management is needed.</span>
<span style="font-size:85%">Boxes in salmon color signify that an urgent management is needed.</span>
 
<span style="font-size:85%">'''Abbreviations:''' '''CT:''' [[CT|Computed tomography]] ; '''CTA:''' [[CTA|Computed tomography angiography]]; '''MRA:''' [[Magnetic resonance angiography]]; '''MRI:''' [[Magnetic resonance imaging]]; '''TEE:''' [[Transesophageal echocardiography]]; '''TTE:''' [[Transthoracic echocardiography]] </span>


{{Family tree/start}}
{{Family tree/start}}
Line 60: Line 62:
</div> }}
</div> }}
{{familytree  | | | | | |!| | }}
{{familytree  | | | | | |!| | }}
{{familytree  | | | | | A02 | | A02=<div style="text-align: left; width: 15em">❑ Order blood cultures (at least 2 sets) <br>❑ Order [[echocardiography]] <br>❑ Evaluate the modified Duke criteria </div>}}
{{familytree  | | | | | A02 | | A02=<div style="text-align: left; width: 15em">❑ Order blood cultures (at least 2 sets) <br>❑ Order [[TTE]], or <br>
❑ Order a [[TEE]] if one or more of the following is present
:❑ Non diagnostic [[TTE]] in a suspected [[infective endocarditis]]
:❑ Clinical complications
:❑ [[ICD|Intracardiac device]] leads
:❑ [[Staphylococcus aureus]] bacteremia without a known cause
:❑ [[Prosthetic valve]] with persistent [[fever]] without [[bacteremia]]
:❑ [[Prosthetic valve]] with a new [[murmur]]
:❑ Nosocomial [[Staphylococcus aureus]] bacteremia with known extra-cardiac port of entry
<br>❑ Evaluate the [[infective endocarditis resident survival guide#Modified Duke Criteria|modified Duke criteria]] </div>}}
{{familytree  | | | | | |!| | }}
{{familytree  | | | | | |!| | }}
{{familytree  | | | | | B01 | | | B01= <div style="text-align: left; width: 15em">'''Identify findings suggestive of complications of endocarditis and requiring urgent intervention'''<br> </div> }}
{{familytree  | | | | | B01 | | | B01= <div style="text-align: left; width: 15em">'''Does the patient have any findings suggestive of complications of endocarditis that require urgent intervention?'''<br> </div> }}
{{familytree  | | | |,|-|^|-|-|-|-|-|-|-|-|v|-|-|-|-|-|-|.| |}}
{{familytree  | | | |,|-|^|-|-|-|-|-|-|-|-|v|-|-|-|-|-|-|.| |}}
{{familytree  | | | B02 | | | | | | | | | B03 | | | | | B04 | B02= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;">Cardiac complications </div>| B03= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;">Extra cardiac complications </div>| B04= <div style=" background: #FFFFFF; text-align: left; width: 15em; padding:1em; color:#000000"> No complications </div>}}
{{familytree  |boxstyle= text-align: left; background: #FA8072; padding: 0;| | | B02 | | | | | | | | | B03 | | | | | B04 | B02=<div style="padding: 5px;">{{fontcolor|#F8F8FF|Yes, the patient has cardiac complications}}</div>| B03= <div style="text-align: left; width: 15em; background: #FA8072; color: #F8F8FF; padding: 5px;">Yes, the patient has extra cardiac complications </div>| B04= <div style=" background: #FFFFFF; text-align: left; padding: 5px; height: 80px; line-height: 20px;"> No, the patient does not have any complications </div>}}
{{familytree  | |,|-|^|-|.| | | | | |,|-|-|^|-|-|.| | | |!| }}
{{familytree  | |,|-|^|-|.| | | | | |,|-|-|^|-|-|.| | | |!| }}


{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| C04 | | C05 | | | | C06 | | | | C07 | | |!| | C04=<div style="text-align: left; width: 15em">❑ [[Dyspnea|<span style="color:white;">Dyspnea </span>]] <br> ❑ [[Edema|<span style="color:white;">Edema</span>]] <br> ❑ Decreased [[ejection fraction|<span style="color:white;">Ejection fraction</span>]] </div> | C05= <div style="text-align: left; width: 15em">❑ Severe valvular insufficiency <br> ❑ Valvular [[abscess|<span style="color:white;">abscess</span>]] <br> ❑ Valvular dehiscence <br> ❑ Valvular rupture <br> ❑ Valvular fistula <br> ❑ Periannular extension of the infection </div>| C06= <div style="text-align: left; width: 15em">'''Focal neurological deficits''' <br> ❑ Facial droop <br> ❑ [[Hemiparesis|<span style="color:white;">Unilateral hemiparesis</span>]] <br> ❑ [[Aphasia|<span style="color:white;">Aphasia</span>]] <br> ❑ [[Hemispatial neglect|<span style="color:white;">Neglect</span>]] <br> ❑ [[Hemianopsia|<span style="color:white;">Hemianopsia</span>]] <br> ❑ [[Headache|<span style="color:white;">Headache</span>]] <br> ❑ [[Altered mental status|<span style="color:white;">Altered mental status</span>]] </div>| C07= <div style="text-align: left; width: 15em">❑ Tender pulsatile mass <br> ❑ [[Hematemesis|<span style="color:white;">Hematemesis</span>]], hematobilia, [[jaundice|<span style="color:white;">jaundice</span>]] (suggestive of involvement of the hepatic artery) <br> ❑ [[Arterial hypertension|<span style="color:white;">Hypertension</span>]] <br> [[Hematuria|<span style="color:white;">Hematuria</span>]] (suggestive of involvement of the renal artery) <br> ❑ Massive [[bloody diarrhea|<span style="color:white;">bloody diarrhea</span>]] (suggestive of involvement of a bowel artery) </div>}}
{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| C04 | | C05 | | | | C06 | | | | C07 | | |!| | C04=<div style="text-align: left; width: 15em">❑ [[Dyspnea|<span style="color:white;">Dyspnea </span>]] <br> ❑ [[Edema|<span style="color:white;">Edema</span>]] <br> ❑ Decreased [[ejection fraction|<span style="color:white;">ejection fraction</span>]] </div> | C05= <div style="text-align: left; width: 15em">❑ [[Valvular disease|<span style="color:white;">Severe valvular insufficiency</span>]] <br> ❑ Valvular [[abscess|<span style="color:white;">abscess</span>]] <br> ❑ Valvular dehiscence <br> ❑ Valvular rupture <br> ❑ Valvular fistula <br> ❑ Periannular extension of the infection </div>| C06= <div style="text-align: left; width: 15em">'''Focal neurological deficits''' <br> ❑ [[Facial droop|<span style="color:white;">Facial droop </span>]] <br> ❑ [[Hemiparesis|<span style="color:white;">Unilateral hemiparesis</span>]] <br> ❑ [[Aphasia|<span style="color:white;">Aphasia</span>]] <br> ❑ [[Hemispatial neglect|<span style="color:white;">Neglect</span>]] <br> ❑ [[Hemianopsia|<span style="color:white;">Hemianopsia</span>]] <br> ❑ [[Headache|<span style="color:white;">Headache</span>]] <br> ❑ [[Altered mental status|<span style="color:white;">Altered mental status</span>]] </div>| C07= <div style="text-align: left; width: 15em">❑ Tender pulsatile mass <br> ❑ [[Hematemesis|<span style="color:white;">Hematemesis</span>]], [[Hemobilia|<span style="color:white;">hemobilia</span>]], [[jaundice|<span style="color:white;">jaundice</span>]] (suggestive of involvement of the hepatic artery) <br> ❑ [[Arterial hypertension|<span style="color:white;">Hypertension</span>]] <br> [[Hematuria|<span style="color:white;">Hematuria</span>]] (suggestive of involvement of the renal artery) <br> ❑ Massive [[bloody diarrhea|<span style="color:white;">bloody diarrhea</span>]] (suggestive of involvement of a bowel artery) </div>}}
{{familytree  | |!| | | |!| | | | | |!| | | | | |!| | | |!| |}}
{{familytree  | |!| | | |!| | | | | |!| | | | | |!| | | |!| |}}
{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| |!| | | |!| | | | | C09 | | | | C10 | | |!| |C09= <div style="text-align: left; width: 15em">❑ Order non contrast [[CT]]<br> ❑ Order [[MRA|<span style="color:white;">MRA</span>]] or [[CTA|<span style="color:white;">CTA</span>]] </div>| C10= ❑ Order [[CT scan|<span style="color:white;">CT scan</span>]] or [[MRI|<span style="color:white;">MRI</span>]]}}
{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| |!| | | |!| | | | | C09 | | | | C10 | | |!| |C09= <div style="text-align: left; width: 15em">❑ Order non contrast head [[CT|<span style="color:white;">CT scan</span>]]<br> ❑ Order [[MRA|<span style="color:white;">MRA</span>]] or [[CTA|<span style="color:white;">CTA</span>]] </div>| C10= ❑ Order abdominal [[CT scan|<span style="color:white;">CT scan</span>]] or [[MRI|<span style="color:white;">MRI</span>]]}}
{{familytree  | |!| | | |!| | | |,|-|^|-|.| | | |!| | | |!| |}}
{{familytree  | |!| | | |!| | | |,|-|^|-|.| | | |!| | | |!| |}}
{{familytree  | D01 | | D02 | | D03 | | D04 | | D05 | | D06 |D01= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Heart failure|<span style="color:white;">Decompensated heart failure</span>]]}} </div>| D02= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| Severe valvular involvement}} </div> | D03= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Embolism|<span style="color:white;">Embolism</span>]] to the brain}} </div> | D04= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| Intracranial mycotic aneurysm}} </div> | D05= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| Extracranial mycotic aneurysm}} </div> | D06= <div style=" background: #FFFFFF; text-align: left; width: 15em; padding:1em"> [[Complete diagnostic approach|Continue with complete diagnostic approach below]]</div>}}
{{familytree  |boxstyle= text-align: left; background: #FA8072; padding: 0;| D01 | | D02 | | D03 | | D04 | | D05 | | D06 |D01= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Heart failure|<span style="color:white;">Decompensated heart failure</span>]]}} </div>| D02= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Valvular disease|<span style="color:white;">Severe valvular involvement </span>]]}} </div> | D03= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Embolism|<span style="color:white;">Embolism</span>]] to the brain}} </div> | D04= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Mycotic aneurysm|<span style="color:white;">Intracranial mycotic aneurysm </span>]]}} </div> | D05= <div style="text-align: left; width: 15em; line-height: 70px; height:70px; background: #FA8072; color: #F8F8FF;"> {{fontcolor|#F8F8FF| [[Mycotic aneurysm|<span style="color:white;">Extracranial mycotic aneurysm </span>]]}} </div> | D06= <div style=" background: #FFFFFF; text-align: left; padding: 5px; color: #999999; height: 100px; line-height: 20px;"> [[Endocarditis resident survival guide#Complete Diagnostic Approach|Continue with the complete diagnostic approach below]]</div>}}
{{familytree  | |!| | | |!| | | |!| | | |!| | | |!| | | }}
{{familytree  | |!| | | |!| | | |!| | | |!| | | |!| | | }}
{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| E01 | | E02 | | E03 | | E04 | | E05 | | E01= <div style="text-align: left; width: 15em">❑ Consider valve replacement surgery<br>❑ [[Acute heart failure resident survival guide|<span style="color:white;">Click here for heart failure resident survival guide</span>]] </div>| E02= <div style="text-align: left; width: 15em">❑ Consider [[valve replacement surgery|<span style="color:white;">valve replacement surgery</span>]] </div>| E03= <div style="text-align: left; width: 15em">❑ [[Stroke resident survival guide|<span style="color:white;">Click here for stroke resident survival guide</span>]] </div>| E04= <div style="text-align: left; width: 15em">❑ Evaluate medical vs surgical intervention</div>| E05= <div style="text-align: left; width: 15em">❑ Consider surgical ligation of the involved artery </div>}}
{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| E01 | | E02 | | E03 | | E04 | | E05 | | E01= <div style="text-align: left; width: 15em">❑ Consider [[valve replacement surgery|<span style="color:white;">valve replacement surgery</span>]]<br>❑ [[Acute heart failure resident survival guide|<span style="color:white;">Click here for heart failure resident survival guide</span>]] </div>| E02= <div style="text-align: left; width: 15em">❑ Consider [[valve replacement surgery|<span style="color:white;">valve replacement surgery</span>]] </div>| E03= <div style="text-align: left; width: 15em">❑ [[Stroke resident survival guide|<span style="color:white;">Click here for stroke resident survival guide</span>]] </div>| E04= <div style="text-align: left; width: 15em">❑ Evaluate medical vs surgical intervention</div>| E05= <div style="text-align: left; width: 15em">❑ Consider surgical ligation of the involved artery </div>}}
{{Family tree/end}}
{{Family tree/end}}


Line 100: Line 111:
❑ [[Hemoptysis]] <BR>
❑ [[Hemoptysis]] <BR>
❑ [[Productive cough]] <BR>
❑ [[Productive cough]] <BR>
❑ [[Flank pain]] (suggestive of septic emboli or [[glomerulonephritis]])<br>
❑ [[Flank pain]] (suggestive of [[septic emboli]] or [[glomerulonephritis]])<br>
❑ [[Hematuria]] (suggestive of septic emboli or [[glomerulonephritis]])<br>
❑ [[Hematuria]] (suggestive of [[septic emboli]] or [[glomerulonephritis]])<br>
❑ [[Seizures]] (suggestive of septic emboli)<BR>
❑ [[Seizures]] (suggestive of [[septic emboli]])<BR>
❑ Focal neurological deficits due to [[stroke]] (suggestive of septic emboli) or [[mycotic aneurysm]]<BR>
❑ Focal neurological deficits due to [[stroke]] (suggestive of [[septic emboli]]) or [[mycotic aneurysm]]<BR>
❑ Reversible focal neurological deficits due to [[transient ischemic attack]] (suggestive of septic emboli)<BR>
❑ Reversible focal neurological deficits due to [[transient ischemic attack]] (suggestive of [[septic emboli]])<BR>
</div>}}
</div>}}
{{familytree | |!| | | | | |}}
{{familytree | |!| | | | | |}}
Line 112: Line 123:
❑ [[Prosthetic valves]]<BR>
❑ [[Prosthetic valves]]<BR>
❑ [[Intravenous drug use]]<BR>
❑ [[Intravenous drug use]]<BR>
:❑ Substances used in the mixture
:❑ Adulterants used in the mixture, such as talc which increases the vulnerability of the valve to infection<ref name="pmid10671344">{{cite journal| author=Frontera JA, Gradon JD| title=Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. | journal=Clin Infect Dis | year= 2000 | volume= 30 | issue= 2 | pages= 374-9 | pmid=10671344 | doi=10.1086/313664 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10671344  }} </ref>
:❑ Sharing the equipment
:❑ Sharing the equipment
:❑ Use of cotton filters (associated with [[cotton fever]])<ref name="pmid2362114">{{cite journal| author=Harrison DW, Walls RM| title="Cotton fever": a benign febrile syndrome in intravenous drug abusers. | journal=J Emerg Med | year= 1990 | volume= 8 | issue= 2 | pages= 135-9 | pmid=2362114 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2362114  }} </ref>
:❑ The process of cleaning the equipment
:❑ The process of cleaning the equipment
❑ Previous [[infective endocarditis]]  <BR>
❑ Previous [[infective endocarditis]]  <BR>
❑ [[Cardiac transplantation]] with valvular abnormality <BR>  
❑ [[Cardiac transplantation]] with valvular abnormality <BR>  
❑ [[Congenital heart diseases]] with a [[shunt]]<BR>
❑ [[Congenital heart diseases]] with a [[shunt]]<BR>
❑ [[Acquired heart diseases]]<BR>
❑ [[Heart disease|Acquired heart diseases]]<BR>
❑ [[Immunodeficiency]] <br>
❑ [[Immunodeficiency]] <br>
❑ Medical procedures <br>
❑ Medical procedures <br>
❑ Surgical procedures <br>
❑ Surgical procedures <br>
❑ Indwelling prosthetic devices
❑ Indwelling [[prosthesis|prosthetic devices]] <br>
❑ Bleeding during toothbrushing <br>
❑ Recent dental procedure
</div>}}
</div>}}
{{familytree | |!| | | | | }}
{{familytree | |!| | | | | }}
Line 138: Line 152:


<table>
<table>
<tr class="v-firstrow"><td>❑ Petechiae </td><td> [[File:Minor Petechia.jpg|200px]]</td></tr>
<tr class="v-firstrow"><td>❑ [[Petechiae]] </td><td> [[File:Minor Petechia.jpg|200px]]</td></tr>
<tr><td>❑ Splinter hemorrhages</td><td>[[File:Splinter hemorrhage.jpg|200px]]</td></tr>
<tr><td>❑ [[Splinter hemorrhages]]</td><td>[[File:Splinter hemorrhage.jpg|200px]]</td></tr>
<tr><td>❑ Osler's nodes</td><td>[[File:Osler's Lesions (Endocarditis).jpg|200px]]</td></tr>
<tr><td>❑ [[Osler's nodes]]</td><td>[[File:Osler's Lesions (Endocarditis).jpg|200px]]</td></tr>
<tr><td>❑ Janeway lesions </td><td>[[File:Skin janeway.jpg|200px]]</td></tr>
<tr><td>❑ [[Janeway lesions]] </td><td>[[File:Skin janeway.jpg|200px]]</td></tr>
</table>
</table>


'''Dental examination'''<br>
'''Oral examination'''<br>
❑ [[Teeth]]<BR>
❑ Poor oral hygiene<ref name="pmid19797553">{{cite journal| author=Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK et al.| title=Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. | journal=J Am Dent Assoc | year= 2009 | volume= 140 | issue= 10 | pages= 1238-44 | pmid=19797553 | doi= | pmc=PMC2770162 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19797553  }} </ref><br>
❑ [[Gingiva]]<BR>
❑ [[Teeth]] looking for [[periodontitis]], [[plaque]] and [[calculus]]<ref name="pmid19797553">{{cite journal| author=Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK et al.| title=Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. | journal=J Am Dent Assoc | year= 2009 | volume= 140 | issue= 10 | pages= 1238-44 | pmid=19797553 | doi= | pmc=PMC2770162 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19797553  }} </ref><BR>
❑ [[Gingiva]] looking for [[gingivitis]]<ref name="pmid19797553">{{cite journal| author=Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK et al.| title=Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. | journal=J Am Dent Assoc | year= 2009 | volume= 140 | issue= 10 | pages= 1238-44 | pmid=19797553 | doi= | pmc=PMC2770162 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19797553  }} </ref><BR>
❑ Recent dental procedure


'''Eyes'''<BR>
'''Eyes'''<BR>
Line 169: Line 185:
❑ [[Abdominal pain]]<BR>
❑ [[Abdominal pain]]<BR>
:❑ [[Flank pain]] (suggestive of [[embolus to the kidney]])<BR>
:❑ [[Flank pain]] (suggestive of [[embolus to the kidney]])<BR>
:❑ Left upper quadrant pain (suggestive of splenic infarct)<BR>
:❑ [[Left upper quadrant pain]] (suggestive of [[splenic infarct]])<BR>
❑ [[Splenomegaly]]<BR>
❑ [[Splenomegaly]]<BR>


'''Extremities'''<BR>
'''Extremities'''<BR>


❑ [[Janeway lesion]]s (painless hemorrhagic cutaneous lesions on the palms and soles)<BR>
❑ [[Janeway lesion]]s (painless hemorrhagic cutaneous lesions on the [[palms]] and [[soles]])<BR>
❑ [[Gangrene]] of fingers<BR>
❑ [[Gangrene]] of fingers<BR>
❑ [[Splinter hemorrhage]]s<BR>
❑ [[Splinter hemorrhage]]s<BR>
Line 188: Line 204:
❑ Order a [[TTE]]<br>
❑ Order a [[TTE]]<br>
❑ Order a [[TEE]] if one or more of the following is present
❑ Order a [[TEE]] if one or more of the following is present
:❑ Non diagnostic [[TTE]] in a suspected infective endocarditis ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ Non diagnostic [[TTE]] in a suspected [[infective endocarditis]] ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ Clinical complications ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ Clinical complications ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ Intracardiac device leads ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ [[ICD|Intracardiac device]] leads ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ [[Staphylococcus aureus]] bacteremia without a known cause ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ [[Staphylococcus aureus]] bacteremia without a known cause ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Prosthetic valve with persistent fever without bacteremia ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ [[Prosthetic valve]] with persistent [[fever]] without [[bacteremia]] ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Prosthetic valve with a new murmur ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ [[Prosthetic valve]] with a new [[murmur]] ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Nosocomial Staphylococcus aureus [[bacteremia]] with known extra-cardiac port of entry ([[ACC AHA guidelines classification scheme|Class IIb, level of evidence B]])
:❑ Nosocomial [[Staphylococcus aureus]] [[bacteremia]] with known extra-cardiac port of entry ([[ACC AHA guidelines classification scheme|Class IIb, level of evidence B]])
</div>}}
</div>}}
{{familytree | |!| | | | | |}}
{{familytree | |!| | | | | |}}
Line 202: Line 218:
<tr class="v-firstrow"><th>Probability of infective endocaritis</th><th> Characteristics </th></tr>
<tr class="v-firstrow"><th>Probability of infective endocaritis</th><th> Characteristics </th></tr>
<tr><td>'''Definite diagnosis by pathological criteria'''</td><td>❑ Microorganisms demonstrated by culture or histological examination<br> of a vegetation, OR <br>
<tr><td>'''Definite diagnosis by pathological criteria'''</td><td>❑ Microorganisms demonstrated by culture or histological examination<br> of a vegetation, OR <br>
❑ Pathological lesions; vegetation or intracardiac abscess confirmed by histological<br> examination showing active endocarditis </td></tr>
❑ Pathological lesions; vegetation or intracardiac abscess confirmed by histological<br> examination showing active [[endocarditis]] </td></tr>
<tr><td>'''Definite diagnosis by clinical criteria'''</td><td>❑ 2 [[Endocarditis resident survival guide #Modified Duke Criteria|major criteria]], OR <br>
<tr><td>'''Definite diagnosis by clinical criteria'''</td><td>❑ 2 [[Endocarditis resident survival guide #Modified Duke Criteria|major criteria]], OR <br>
❑ 1 [[Endocarditis resident survival guide #Modified Duke Criteria|major criterion]] and 3 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criteria]], OR <br>
❑ 1 [[Endocarditis resident survival guide #Modified Duke Criteria|major criterion]] and 3 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criteria]], OR <br>
❑ 5 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criteria]] </td></tr>
❑ 5 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criteria]] </td></tr>
<tr><td>'''Possible diagnosis'''</td><td>❑ 1 [[Endocarditis resident survival guide #Modified Duke Criteria|major criterion]] and 1 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criterion]], OR <br>❑ 3 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criteria]] </td></tr>
<tr><td>'''Possible diagnosis'''</td><td>❑ 1 [[Endocarditis resident survival guide #Modified Duke Criteria|major criterion]] and 1 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criterion]], OR <br>❑ 3 [[Endocarditis resident survival guide #Modified Duke Criteria|minor criteria]] </td></tr>
<tr><td>'''Rejected diagnosis'''</td><td>❑ Firm alternative diagnosis explaining evidence of IE, OR <br>
<tr><td>'''Rejected diagnosis'''</td><td>❑ Firm alternative diagnosis explaining evidence of [[infective endocarditis]], OR <br>
❑ Resolution of IE syndrome with antibiotic therapy for 4 days, OR <br>
❑ Resolution of [[infective endocarditis]] with [[antibiotic therapy]] for 4 days, OR <br>
❑ No pathological evidence of IE at surgery or autopsy, with antibiotic therapy for 4 days, OR <br>
❑ No pathological evidence of [[infective endocarditis]] at surgery or [[autopsy]], with [[antibiotic therapy]] for 4 days, OR <br>
❑ Does not meet [[Endocarditis resident survival guide #Modified Duke Criteria|criteria]] for possible IE as above</td></tr>
❑ Does not meet [[Endocarditis resident survival guide #Modified Duke Criteria|criteria]] for possible [[infective endocarditis]] as above</td></tr>
</table></div>}}
</table></div>}}
{{familytree | |!| | | | | |}}
{{familytree | |!| | | | | |}}
Line 221: Line 237:
❑ [[Marantic endocarditis]]
❑ [[Marantic endocarditis]]
:❑ Valvular vegetations
:❑ Valvular vegetations
:❑ Negative blood culture
:❑ Negative [[blood culture]]
:❑ Hypercoagulable state, [[lupus]] or [[antiphospholipid syndrome]]
:❑ Hypercoagulable state, [[lupus]] or [[antiphospholipid syndrome]]
❑ [[Cellulitis]] (skin inflammatory skin)<br>
❑ [[Cellulitis]] (skin inflammatory skin)<br>
Line 228: Line 244:
❑ [[Prosthetic joint]] infection (localized inflammatory signs) <br>
❑ [[Prosthetic joint]] infection (localized inflammatory signs) <br>
❑ [[Pneumonia]] <br>
❑ [[Pneumonia]] <br>
❑ [[Osteomyelitis]]
❑ [[Osteomyelitis]]<br>
</div> }}
❑ [[Fever of unknown origin]]
❑ [[Cotton fever]]<ref name="pmid2362114">{{cite journal| author=Harrison DW, Walls RM| title="Cotton fever": a benign febrile syndrome in intravenous drug abusers. | journal=J Emerg Med | year= 1990 | volume= 8 | issue= 2 | pages= 135-9 | pmid=2362114 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2362114  }} </ref></div> }}
{{Familytree/end}}
{{Familytree/end}}


Line 240: Line 257:
{{familytree | | | G01 | | | | | G01=<div style="float: left; text-align: left; width: 40em; padding:1em;">'''Once the diagnosis of infective endocarditis is confirmed, initiate the treatment:'''
{{familytree | | | G01 | | | | | G01=<div style="float: left; text-align: left; width: 40em; padding:1em;">'''Once the diagnosis of infective endocarditis is confirmed, initiate the treatment:'''
❑ Begin [[Endocarditis antimicrobial treatment|antibiotic treatment]]<br>
❑ Begin [[Endocarditis antimicrobial treatment|antibiotic treatment]]<br>
❑ Order blood cultures every 24-48 hours until no [[bacteremia]] can be detected<br>
❑ Order [[blood cultures]] every 24-48 hours until no [[bacteremia]] can be detected<br>
❑ Temporarily discontinue [[anticoagulation]] if one of the following is present
❑ Temporarily discontinue [[anticoagulation]] if one of the following is present
:❑ Signs and symptoms of [[CNS]] involvement consistent with embolism or [[stroke]] ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Signs and symptoms of [[CNS]] involvement consistent with [[embolism]] or [[stroke]] ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Vitamin K antagonist administration ([[ACC AHA guidelines classification scheme|Class IIb, level of evidence B]])
:❑ [[Vitamin K antagonist]] administration ([[ACC AHA guidelines classification scheme|Class IIb, level of evidence B]])
❑ Remove the [[pacemaker]] of the defibrillator system if one of the following is present
❑ Remove the [[pacemaker]] of the [[defibrillator|defibrillator system]] if one of the following is present
:❑ Documented infection of the device or leads ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ Documented infection of the device or leads ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])
:❑ Valvular infective endocarditis by Staphylococcus aureus or fungi in the absence of documented infection of the device or leads ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Valvular [[infective endocarditis]] by [[Staphylococcus aureus]] or [[fungi]] in the absence of documented infection of the device or leads ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Patient scheduled for valve surgery ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence C]])
:❑ Patient scheduled for [[valve surgery]] ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence C]])
:❑ Persistent vegetations and recurrent emboli despite the antibiotic regimen ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
:❑ Persistent vegetations and recurrent [[emboli]] despite the [[antibiotic]] regimen ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]])
❑ Manage the patient with a multidisciplinary team<br>
❑ Manage the patient with a multidisciplinary team<br>
:❑ Consult an infectious disease specialist
:❑ Consult an infectious disease specialist
Line 256: Line 273:
{{familytree | | | D02 | | D02= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Does the patient have any of the following conditions that require an early [[valve replacement surgery]] during hospitalization?'''<br>
{{familytree | | | D02 | | D02= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Does the patient have any of the following conditions that require an early [[valve replacement surgery]] during hospitalization?'''<br>
❑ [[Heart failure]] due to the valve dysfunction ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) <br>
❑ [[Heart failure]] due to the valve dysfunction ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) <br>
❑ Left sided infective endocarditis due to [[staphylococcus aureus]], fungal or highly resistant organisms ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) <br>
❑ Left sided [[infective endocarditis]] due to [[staphylococcus aureus]], fungal or highly resistant organisms ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) <br>
❑ [[Heart block]], annular or aortic [[abscess]] or destructive lesions ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) <br>
❑ [[Heart block]], annular or aortic [[abscess]] or destructive lesions ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) <br>
❑ Persistent [[bacteremia]] or [[fever]] 5 to 7 following the initiation of the antibiotics ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]) </div>}}
❑ Persistent [[bacteremia]] or [[fever]] 5 to 7 following the initiation of the [[antibiotics]] ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]])<br>
❑ Relapse of the infection depsite a complete course of [[antibiotics]] in prosthetic valve endocarditis when no portal of infection can be identified ([[ACC AHA guidelines classification scheme|Class I, level of evidence C]])<br>
❑ Recurrent [[emboli]] and persistent vegetations despite antibiotic therapy ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]]) <br>
❑ Mobile vegetations with a length more than 10 mm in native valve endocarditis([[ACC AHA guidelines classification scheme|Class IIb, level of evidence B]])
</div>}}
{{familytree | | |,|^|.| | |}}
{{familytree | | |,|^|.| | |}}
{{familytree | D03 | | D04 | D03= '''Yes'''| D04= '''No'''}}
{{familytree | D03 | | D04 | D03= '''Yes'''| D04= '''No'''}}
Line 266: Line 287:
{{familytree | | | F01 | | | | | F01=<div style="float: left; text-align: left; width: 40em; padding:1em;"> '''Follow up the patient:'''<br>
{{familytree | | | F01 | | | | | F01=<div style="float: left; text-align: left; width: 40em; padding:1em;"> '''Follow up the patient:'''<br>
❑ Repeat [[TTE]] before discharge<br>
❑ Repeat [[TTE]] before discharge<br>
❑ Refer for cessation of drug abuse (if applicable) <br>
❑ Refer for cessation of [[drug abuse]] (if applicable) <br>
❑ Educate the patient about the signs and symptoms of infective endocarditis <br>
❑ Educate the patient about the signs and symptoms of infective endocarditis <br>
❑ Recommend a thorough dental examination <br>
❑ Recommend a thorough dental examination <br>
Line 272: Line 293:
:❑ Relapse ([[fever]], [[chills]])
:❑ Relapse ([[fever]], [[chills]])
:❑ New or worsening [[heart failure]]
:❑ New or worsening [[heart failure]]
:❑ Antibiotic toxicity
:❑ [[Antibiotic]] toxicity
::❑ Vestibular toxicity
::❑ Vestibular toxicity
::❑ [[Diarrhea]] or [[colitis]]
::❑ [[Diarrhea]] or [[colitis]]
Line 279: Line 300:
{{familytree | | | G01 | | | | | G01=<div style="float: left; text-align: left; width: 40em; padding:1em;"> '''Reevaluate the patient with TTE and/or TEE if one of the following is present:'''<br>
{{familytree | | | G01 | | | | | G01=<div style="float: left; text-align: left; width: 40em; padding:1em;"> '''Reevaluate the patient with TTE and/or TEE if one of the following is present:'''<br>
❑ Change in clinical signs and symptoms
❑ Change in clinical signs and symptoms
:❑ New murmur
:❑ New [[murmur]]
:❑ [[Embolism]]
:❑ [[Embolism]]
:❑ Persistent [[fever]]
:❑ Persistent [[fever]]
:❑ [[Heart failure]]
:❑ [[Heart failure]]
:❑ [[Abscess]]
:❑ [[Abscess]]
:❑ Atrioventricular heart block
:❑ [[Atrioventricular heart block]]
❑ High risk of complications
❑ High risk of complications
:❑ Large vegetations on [[echocardiogram]]
:❑ Large vegetations on [[echocardiogram]]
:❑ Staphylococcus, enterecoccal, or fungal infections
:❑ [[Staphylococcus]], [[enterococcus|enterecoccal]], or [[fungi|fungal]] infections
</div>}}
</div>}}
{{familytree/end}}
{{familytree/end}}
Line 311: Line 332:
:❑ [[Enterococci]] <br>
:❑ [[Enterococci]] <br>
<br>OR<br><br>
<br>OR<br><br>
❑ Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:<BR>
❑ Microorganisms consistent with [[infective endocarditis]] from persistently positive [[blood cultures]] defined as:<BR>
:❑ At least 2 positive cultures of blood samples drawn >12 hours apart, or<BR>
:❑ At least 2 positive cultures of blood samples drawn >12 hours apart, or<BR>
:❑ All of 3 or a majority of 4 separate cultures of blood (with first and last sample drawn 1 hour apart)<br>
:❑ All of 3 or a majority of 4 separate cultures of blood (with first and last sample drawn 1 hour apart)<br>
<br>OR<br><br>
<br>OR<br><br>
❑ Single positive blood culture for Coxiella burnetii or anti–phase 1 IgG antibody titer >1:800<br>
❑ Single positive [[blood culture]] for [[Coxiella burnetii]] or anti–phase 1 IgG antibody titer >1:800<br>
<br>
<br>
-----
-----
'''''2-Echocardiographic evidence of endocardial involvement''''' <br>
'''''2-Echocardiographic evidence of endocardial involvement''''' <br>
❑ Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation, or<br>
❑ Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation, or<br>
❑ Abscess, or<BR>
[[Abscess]], or<BR>
❑ New partial dehiscence of prosthetic valve, or<BR>
❑ New partial dehiscence of [[prosthetic valve]], or<BR>
❑ New valvular regurgitation
❑ New [[valvular disease|valvular regurgitation]]
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''1- Predisposition'''''<br>
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''1- Predisposition'''''<br>
❑ Predisposing heart condition or intravenous drug use<BR>
❑ Predisposing heart condition or intravenous drug use<BR>
Line 348: Line 369:
----
----
'''''5- Microbiological evidence''''' <br>
'''''5- Microbiological evidence''''' <br>
❑ Positive blood culture but does not meet a major criterion as noted above<br>
❑ Positive [[blood culture]] but does not meet a major criterion as noted above<br>
<br>OR<br><br>
<br>OR<br><br>
❑ Serological evidence of active infection with organism consistent with infectious endocarditis<BR>
❑ Serological evidence of active infection with organism consistent with [[infectious endocarditis]]<BR>
|-
|-
|}
|}
|}
|}
<br>
<br>
==Prophylaxis==
Shown below is an algorithm depicting the general prophylactic approaches of [[infective endocarditis]].<ref name="pmid17446442">{{cite journal| author=Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M et al.| title=Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. | journal=Circulation | year= 2007 | volume= 116 | issue= 15 | pages= 1736-54 | pmid=17446442 | doi=10.1161/CIRCULATIONAHA.106.183095 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17446442  }} </ref><ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>
{{familytree/start |summary=Diagnostic approach}}
{{familytree | A01 | |A01= <div style="float: Left; text-align: left; width: 40em; padding:1em;">'''Identify high risk patients:''' ([[ACC AHA guidelines classification scheme|Class IIa, Level of evidence B]])
❑ [[Prosthetic valves]] patients<BR>
❑ Previous [[infective endocarditis]]  <BR>
❑ [[Cardiac transplant]] recipients with valves regurgitation due to structurally abnormal valve<BR>
❑ [[Congenital heart diseases]]<BR>
:❑ Unrepaired cyanotic [[congenital heart diseases]]
:❑ Completely repaired defect with prosthetic material or device
:❑ Repaired with residual defects</div>}}
{{familytree | |!| | |}}
{{familytree | B01 | |B01= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Identify high risk procedures:'''<BR>
❑ [[Endocarditis antibiotic prophylaxis#Basis for AHA Recommendations Regarding Antibiotic Prophylaxis for Dental Procedures|Dental procedures]]
:❑ Manipulation of gingival tissue, or
:❑ Manipulation of the periapical region of teeth, or
:❑ Perforation of the oral mucosa
❑ [[Endocarditis antibiotic prophylaxis#Antibiotic Prophylaxis For Respiratory Tract Procedures|Respiratory tract procedures]] involving incision of the respiratory tract mucosa<br>
:❑ [[Tonsillectomy]]
:❑ [[Adenoidectomy]]
❑ [[Endocarditis antibiotic prophylaxis#Antibiotic Prophylaxis for Gastrointestinal (GI) and Genitourinary (GU) Procedures|Gastrointestinal (GI) and genitourinary (GU) procedures]] only if GI or GU tract infection is present<br>
</div>}}
{{Familytree | |!| | |}}
{{Familytree | C01 | |C01= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''❑ Administer prophylaxis'''
</div>}}
{{Familytree/end}}
===Antibiotic Prophylaxis===
Shown below is a table depicting the prophylaxis antibiotic regimes for [[infective endocarditis]].<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>
{| style="background: #FFFFFF;"
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 600px;"
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center colspan="2"| {{fontcolor|#FFF|Infective Endocarditis Antibiotic Prophylaxis}}
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center colspan="2" | '''''Oral treatment is tolerated'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left | '''''Not allergic to penicillin'''''|| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left|'''''Allergic to penicillin'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left |▸ '''''[[Amoxicillin]] 2 g'''''|| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left|▸ '''''[[Ampicillin]] 2 g IM or IV'''''<br> ''OR'' <br>▸ '''''[[Cefazolin]] 1 g IM or IV''''' <br> ''OR'' <br>▸ '''''[[Ceftriaxone]] 1 g IM or IV'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center colspan="2" | '''''Oral treatment is not tolerated'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left | '''''Not allergic to penicillin'''''|| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left|'''''Allergic to penicillin'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left |▸ '''''[[Cefalexin]] 2 g''''' <br> ''OR'' <br>▸ '''''[[Clindamycin]] 600 mg''''' <br> ''OR'' <br>▸ '''''[[Azithromycin]] 500 mg''''' <br> ''OR'' <br>▸ '''''[[Clarithromycin]] 500 mg''''' || style="padding: 0 5px; font-size: 90%; background: #DCDCDC;" align=left|▸ '''''[[Cefazolin]] 1 g IM or IV''''' <br> ''OR'' <br>▸ '''''[[Ceftriaxone]] 1 g IM or IV'''''<br> ''OR'' <br>▸ '''''[[Clindamycin]] 600 mg IM or IV'''''
|-
|}
|}


==Do's==
==Do's==
* Elicit a full medical history to identify the minor Duke criteria for the diagnosis.
* Elicit a full medical history to identify the minor Duke criteria for the diagnosis.
* Consider alternative diagnoses for [[bacteremia]] and [[fever]] by searching for focus of infections.
* Consider alternative diagnoses for [[bacteremia]] and [[fever]] by searching for the cause of the infection.
* Initiate antibiotic therapy after withdrawing blood for culture ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>
* Initiate [[antibiotic therapy]] after withdrawing [[blood]] for culture ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>


* If the blood cultures are negative in a patient suspected to have [[infective endocarditis]], suspect HACEK infection and ask the laboratory to retain the [[blood cultures]] for more than two weeks.<ref name="Baddour-2005">{{Cite journal  | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>
* If the [[blood cultures]] are negative in a patient suspected to have [[infective endocarditis]], suspect [[HACEK]] infection and ask the laboratory to retain the [[blood cultures]] for more than two weeks.<ref name="Baddour-2005">{{Cite journal  | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>


* If HACEK bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.<ref name="Baddour-2005">{{Cite journal  | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>
* If [[HACEK]] bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.<ref name="Baddour-2005">{{Cite journal  | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref>


* Do a [[TEE]] intraoperatively among patients scheduled for valve surgery for infective endocarditis ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>
* Do a [[transesophageal echocardiography]] intraoperatively among patients scheduled for valve surgery for [[infective endocarditis]] ([[ACC AHA guidelines classification scheme|Class I, level of evidence B]]).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>


* Consider ordering a cardiac CT scan when echocardiography does not provide clear details about the cardiac anatomy in the context of suspected paravalvular infections ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]]).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>
* Consider ordering a cardiac [[CT scan]] when [[echocardiography]] does not provide clear details about the cardiac anatomy in the context of suspected paravalvular infections ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]]).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>


* Suspect intraventricular septal [[abscess]] as a complication of endocarditis when the [[ECG]] is significant for a gradual increase in the [[PR interval]] or a new [[left bundle branch block]].<ref name="pmid3516105">{{cite journal| author=Weinstein L| title=Life-threatening complications of infective endocarditis and their management. | journal=Arch Intern Med | year= 1986 | volume= 146 | issue= 5 | pages= 953-7 | pmid=3516105 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3516105  }} </ref>
* Suspect intraventricular septal [[abscess]] as a complication of endocarditis when the [[ECG]] is significant for a gradual increase in the [[PR interval]] or a new [[left bundle branch block]].<ref name="pmid3516105">{{cite journal| author=Weinstein L| title=Life-threatening complications of infective endocarditis and their management. | journal=Arch Intern Med | year= 1986 | volume= 146 | issue= 5 | pages= 953-7 | pmid=3516105 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3516105  }} </ref>


==Don'ts==
==Don'ts==
* Don't administer prophylaxis for infective endocarditis in patients with valvular heart disease who are at risk infective endocarditis for procedures such as [[TEE]], [[cystoscopy]], [[esophagogastroduodenoscopy]] or [[colonoscopy]] without any evidence of active infection (Class III; level of evidence B).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>
* Don't administer [[Endocarditis antibiotic prophylaxis|prophylaxis for infective endocarditis]] in patients with valvular heart disease who are at risk infective endocarditis for procedures such as [[TEE|transesophageal echocardiography]], [[cystoscopy]], [[esophagogastroduodenoscopy]] or [[colonoscopy]] without any evidence of active infection (Class III; level of evidence B).<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher =  | date =  | accessdate = 4 March 2014 }}</ref>


* Do not administer infective endocarditis prophylaxis for the following dental procedures:
* Do not administer infective endocarditis prophylaxis for the following dental procedures:
Line 433: Line 402:
** Placement or removal of prosthodontic or orthodontic appliances
** Placement or removal of prosthodontic or orthodontic appliances
** Adjustment of orthodontic appliances
** Adjustment of orthodontic appliances
** [[Bleeding]] following trauma to the oral mucosa or lips<ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>
** [[Bleeding]] following [[trauma]] to the [[oral mucosa]] or [[lips]]<ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>


* Do not administer infective endocarditis prophylaxis for procedures involving the [[respiratory tract]] unless they involve incision of the respiratory tract [[mucosa]].<ref name="pmid18820172">{{cite journal| author=Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al.| title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=Circulation | year= 2008 | volume= 118 | issue= 15 | pages= e523-661 | pmid=18820172 | doi=10.1161/CIRCULATIONAHA.108.190748 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18820172  }} </ref>
* Do not administer [[Endocarditis antibiotic prophylaxis|prophylaxis for infective endocarditis]] for procedures involving the [[respiratory tract]] unless they involve incision of the respiratory tract [[mucosa]].<ref name="pmid18820172">{{cite journal| author=Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al.| title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=Circulation | year= 2008 | volume= 118 | issue= 15 | pages= e523-661 | pmid=18820172 | doi=10.1161/CIRCULATIONAHA.108.190748 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18820172  }} </ref>


* Do not administer [[cephalosporins]] in subjects with a previous history of [[anaphylaxis]], [[angioedema]], or [[urticaria]] following [[penicillin]] or [[ampicillin]] use.
* Do not administer [[cephalosporins]] in subjects with a previous history of [[anaphylaxis]], [[angioedema]], or [[urticaria]] following [[penicillin]] or [[ampicillin]] use.

Latest revision as of 14:15, 19 August 2020

For infective endocarditis prevention resident survival guide click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farman Khan, MD, MRCP [2]; Mohamed Moubarak, M.D. [3]; Rim Halaby, M.D. [4]

Infective endocarditis Resident Survival Guide Microchapters
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts

Overview

Infective endocarditis is an infection in the endothelium of the heart, including but not limited to the valves. While acute bacterial endocarditis is caused by an infection with a virulent organism such as staphylococcus aureus, group A or other beta-hemolytic streptococci, subacute bacterial endocarditis is an indolent infection with less virulent organisms like streptococcus viridans. Patients with unexplained fever for more than 48 hours and who are at high risk for infective endocarditis and patients among whom valve regurgitation is newly diagnosed should undergo a diagnostic workup to rule out endocarditis. The diagnosis of endocarditis depends on a thorough history and physical exam as well as the results of blood cultures and the findings on transthoracic echocardiogram or transesophageal echocardiogram. The modified Duke criteria is used to establish the diagnosis of endocarditis. Endocarditis is initially treated with empiric antibiotic therapy until the causative agent is identified.[1][2]

Causes

Life Threatening Causes

Acute endocarditis is a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[1][3]

Boxes in salmon color signify that an urgent management is needed.

Abbreviations: CT: Computed tomography ; CTA: Computed tomography angiography; MRA: Magnetic resonance angiography; MRI: Magnetic resonance imaging; TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography

 
 
 
 
Identify cardinal signs and symptoms that increase the pretest probability of endocarditis

❑ Persistent fever
❑ New valvular regurgitation murmur
Bacteremia
Janeway lesion
Osler's node
Roth's spots
Glomerulonephritis
❑ New AV block
❑ High risk factors

❑ Pre-existing cardiac abnormality
Prosthetic valve
❑ Recent surgical or medical procedures
❑ Intravenous drug use
❑ Recent bacterial infection
❑ History of previous endocarditis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Order blood cultures (at least 2 sets)
❑ Order TTE, or

❑ Order a TEE if one or more of the following is present

❑ Non diagnostic TTE in a suspected infective endocarditis
❑ Clinical complications
Intracardiac device leads
Staphylococcus aureus bacteremia without a known cause
Prosthetic valve with persistent fever without bacteremia
Prosthetic valve with a new murmur
❑ Nosocomial Staphylococcus aureus bacteremia with known extra-cardiac port of entry

❑ Evaluate the modified Duke criteria
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any findings suggestive of complications of endocarditis that require urgent intervention?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes, the patient has cardiac complications
 
 
 
 
 
 
 
 
Yes, the patient has extra cardiac complications
 
 
 
 
No, the patient does not have any complications
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dyspnea
Edema
❑ Decreased ejection fraction
 
Severe valvular insufficiency
❑ Valvular abscess
❑ Valvular dehiscence
❑ Valvular rupture
❑ Valvular fistula
❑ Periannular extension of the infection
 
 
 
Focal neurological deficits
Facial droop
Unilateral hemiparesis
Aphasia
Neglect
Hemianopsia
Headache
Altered mental status
 
 
 
❑ Tender pulsatile mass
Hematemesis, hemobilia, jaundice (suggestive of involvement of the hepatic artery)
Hypertension
Hematuria (suggestive of involvement of the renal artery)
❑ Massive bloody diarrhea (suggestive of involvement of a bowel artery)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Order non contrast head CT scan
❑ Order MRA or CTA
 
 
 
❑ Order abdominal CT scan or MRI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Embolism to the brain
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Evaluate medical vs surgical intervention
 
❑ Consider surgical ligation of the involved artery
 

Complete Diagnostic Approach

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][2]

Abbreviations: TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography

Characterize the symptoms:

❑ Onset of the symptoms

❑ Acute
❑ Subacute

Fever
Chills
Rigors
Sweats
Fatigue
Pleuritic chest pain
Back pain
Weakness
Myalgias
Arthralgias
Anorexia
Shortness of breath
Hemoptysis
Productive cough
Flank pain (suggestive of septic emboli or glomerulonephritis)
Hematuria (suggestive of septic emboli or glomerulonephritis)
Seizures (suggestive of septic emboli)
❑ Focal neurological deficits due to stroke (suggestive of septic emboli) or mycotic aneurysm
❑ Reversible focal neurological deficits due to transient ischemic attack (suggestive of septic emboli)

 
 
 
 
 
 
 
 
 
 
 
 
Identify existing risk factors for endocarditis:

❑ History of rheumatic heart disease
Prosthetic valves
Intravenous drug use

❑ Adulterants used in the mixture, such as talc which increases the vulnerability of the valve to infection[4]
❑ Sharing the equipment
❑ Use of cotton filters (associated with cotton fever)[5]
❑ The process of cleaning the equipment

❑ Previous infective endocarditis
Cardiac transplantation with valvular abnormality
Congenital heart diseases with a shunt
Acquired heart diseases
Immunodeficiency
❑ Medical procedures
❑ Surgical procedures
❑ Indwelling prosthetic devices
❑ Bleeding during toothbrushing
❑ Recent dental procedure

 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

Vitals
Temperature

Fever

Blood pressure

❑ Wide pulse pressure (suggestive of aortic insufficiency)
❑ Narrow pulse pressure (suggestive of left ventricular failure)

Skin

Petechiae
Splinter hemorrhages
Osler's nodes
Janeway lesions

Oral examination
❑ Poor oral hygiene[6]
Teeth looking for periodontitis, plaque and calculus[6]
Gingiva looking for gingivitis[6]
❑ Recent dental procedure

Eyes

Conjunctival hemorrhage
Roth's spots in the retina

Cardiovascular examination

Heart murmur: New or change in the character of a previous murmur

Aortic insufficiency (early diastolic, decrescendo, best heard in the left sternal border)
Tricuspid regurgitation (holosystolic, best heard over the fourth intercostal area at left sternal border)
Mitral regurgitation (holosystolic, best heard at the apex)

Respiratory examination

Rales (suggestive of heart failure)

Abdominal examination

Reduced bowel sounds (suggestive of mesenteric embolization or ileus)
Abdominal pain

Flank pain (suggestive of embolus to the kidney)
Left upper quadrant pain (suggestive of splenic infarct)

Splenomegaly

Extremities

Janeway lesions (painless hemorrhagic cutaneous lesions on the palms and soles)
Gangrene of fingers
Splinter hemorrhages
Osler's nodes (painful subcutaneous lesions in the distal fingers)

Neurological examination

❑ Full neurological exam

❑ Focal deficits (suggestive of stroke or brain abscess)
 
 
 
 
 
 
 
 
 
 
 
 
Order tests:

Blood culture (at least two sets)
❑ Order a TTE
❑ Order a TEE if one or more of the following is present

❑ Non diagnostic TTE in a suspected infective endocarditis (Class I, level of evidence B)
❑ Clinical complications (Class I, level of evidence B)
Intracardiac device leads (Class I, level of evidence B)
Staphylococcus aureus bacteremia without a known cause (Class IIa, level of evidence B)
Prosthetic valve with persistent fever without bacteremia (Class IIa, level of evidence B)
Prosthetic valve with a new murmur (Class IIa, level of evidence B)
❑ Nosocomial Staphylococcus aureus bacteremia with known extra-cardiac port of entry (Class IIb, level of evidence B)
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate the Modified Duke Criteria for infective endocarditis:[7]
Probability of infective endocaritis Characteristics
Definite diagnosis by pathological criteria❑ Microorganisms demonstrated by culture or histological examination
of a vegetation, OR
❑ Pathological lesions; vegetation or intracardiac abscess confirmed by histological
examination showing active endocarditis
Definite diagnosis by clinical criteria❑ 2 major criteria, OR

❑ 1 major criterion and 3 minor criteria, OR

❑ 5 minor criteria
Possible diagnosis❑ 1 major criterion and 1 minor criterion, OR
❑ 3 minor criteria
Rejected diagnosis❑ Firm alternative diagnosis explaining evidence of infective endocarditis, OR

❑ Resolution of infective endocarditis with antibiotic therapy for 4 days, OR
❑ No pathological evidence of infective endocarditis at surgery or autopsy, with antibiotic therapy for 4 days, OR

❑ Does not meet criteria for possible infective endocarditis as above
 
 
 
 
 
 
 
 
 
 
 
 
Consider alternative diagnoses:

❑ Culture negative endocarditis

❑ Previous treatment with antibiotics
❑ Fastidious bacterial infection
Fungal infection
❑ Inappropriate blood culture technique

Marantic endocarditis

❑ Valvular vegetations
❑ Negative blood culture
❑ Hypercoagulable state, lupus or antiphospholipid syndrome

Cellulitis (skin inflammatory skin)
Catheter related infection (presence of catheter associated with associated local erythema and tenderness)
Cardiac device infection
Prosthetic joint infection (localized inflammatory signs)
Pneumonia
Osteomyelitis
Fever of unknown origin

Cotton fever[5]
 
 
 
 

Treatment

Shown below is an algorithm depicting the management of infective endocarditis.[1][2]

Abbreviations: TEE: Transesophageal echocardiography; TTE: Transthoracic echocardiography

 
 
Once the diagnosis of infective endocarditis is confirmed, initiate the treatment:

❑ Begin antibiotic treatment
❑ Order blood cultures every 24-48 hours until no bacteremia can be detected
❑ Temporarily discontinue anticoagulation if one of the following is present

❑ Signs and symptoms of CNS involvement consistent with embolism or stroke (Class IIa, level of evidence B)
Vitamin K antagonist administration (Class IIb, level of evidence B)

❑ Remove the pacemaker of the defibrillator system if one of the following is present

❑ Documented infection of the device or leads (Class I, level of evidence B)
❑ Valvular infective endocarditis by Staphylococcus aureus or fungi in the absence of documented infection of the device or leads (Class IIa, level of evidence B)
❑ Patient scheduled for valve surgery (Class IIa, level of evidence C)
❑ Persistent vegetations and recurrent emboli despite the antibiotic regimen (Class IIa, level of evidence B)

❑ Manage the patient with a multidisciplinary team

❑ Consult an infectious disease specialist
❑ Consult a cardiologist
❑ Consult a cardiac surgeon
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following conditions that require an early valve replacement surgery during hospitalization?

Heart failure due to the valve dysfunction (Class I, level of evidence B)
❑ Left sided infective endocarditis due to staphylococcus aureus, fungal or highly resistant organisms (Class I, level of evidence B)
Heart block, annular or aortic abscess or destructive lesions (Class I, level of evidence B)
❑ Persistent bacteremia or fever 5 to 7 following the initiation of the antibiotics (Class I, level of evidence B)
❑ Relapse of the infection depsite a complete course of antibiotics in prosthetic valve endocarditis when no portal of infection can be identified (Class I, level of evidence C)
❑ Recurrent emboli and persistent vegetations despite antibiotic therapy (Class IIa, level of evidence B)
❑ Mobile vegetations with a length more than 10 mm in native valve endocarditis(Class IIb, level of evidence B)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
❑ Schedule for early surgery
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow up the patient:

❑ Repeat TTE before discharge
❑ Refer for cessation of drug abuse (if applicable)
❑ Educate the patient about the signs and symptoms of infective endocarditis
❑ Recommend a thorough dental examination
❑ Monitor for complications

❑ Relapse (fever, chills)
❑ New or worsening heart failure
Antibiotic toxicity
❑ Vestibular toxicity
Diarrhea or colitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reevaluate the patient with TTE and/or TEE if one of the following is present:

❑ Change in clinical signs and symptoms

❑ New murmur
Embolism
❑ Persistent fever
Heart failure
Abscess
Atrioventricular heart block

❑ High risk of complications

❑ Large vegetations on echocardiogram
Staphylococcus, enterecoccal, or fungal infections
 
 
 
 

Antibiotic Regimens

A complete list of pathogen specific antibiotics regimens with appropriate dosages and duration of treatment is available here.

Modified Duke Criteria

Shown below is a table summarizing the major and minor Modified Duke Criteria.[7]

Modified Duke Criteria
Major criteria Minor criteria
1- Positive Blood Culture for Infective Endocarditis

❑ Typical microorganism consistent with infective endocarditis from 2 separate blood cultures, in the absence of a primary focus:

Viridans streptococci, streptococcus bovis
HACEK group
❑ Community-acquired staphylococcus aureus
Enterococci


OR

❑ Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:

❑ At least 2 positive cultures of blood samples drawn >12 hours apart, or
❑ All of 3 or a majority of 4 separate cultures of blood (with first and last sample drawn 1 hour apart)


OR

❑ Single positive blood culture for Coxiella burnetii or anti–phase 1 IgG antibody titer >1:800


2-Echocardiographic evidence of endocardial involvement
❑ Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation, or
Abscess, or
❑ New partial dehiscence of prosthetic valve, or
❑ New valvular regurgitation

1- Predisposition

❑ Predisposing heart condition or intravenous drug use


2- Fever
❑ Temperature > 38.0° C (100.4° F)


3- Vascular phenomena
Major arterial emboli
❑ Septic pulmonary infarcts
Mycotic aneurysm
Intracranial hemorrhage
Conjunctival hemorrhage
Janeway lesions


4- Immunologic phenomena
Glomerulonephritis
Osler's nodes
Roth spots
Rheumatoid factor


5- Microbiological evidence
❑ Positive blood culture but does not meet a major criterion as noted above

OR

❑ Serological evidence of active infection with organism consistent with infectious endocarditis


Do's

  • If HACEK bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.[2]

Don'ts

  • Do not administer infective endocarditis prophylaxis for the following dental procedures:
    • Anesthetic injections in noninfected tissue
    • Dental radiographs
    • Shedding of deciduous teeth
    • Placement of orthodontic brackets
    • Placement or removal of prosthodontic or orthodontic appliances
    • Adjustment of orthodontic appliances
    • Bleeding following trauma to the oral mucosa or lips[8]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.
  2. 2.0 2.1 2.2 2.3 2.4 Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Weinstein L (1986). "Life-threatening complications of infective endocarditis and their management". Arch Intern Med. 146 (5): 953–7. PMID 3516105.
  4. Frontera JA, Gradon JD (2000). "Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis". Clin Infect Dis. 30 (2): 374–9. doi:10.1086/313664. PMID 10671344.
  5. 5.0 5.1 Harrison DW, Walls RM (1990). ""Cotton fever": a benign febrile syndrome in intravenous drug abusers". J Emerg Med. 8 (2): 135–9. PMID 2362114.
  6. 6.0 6.1 6.2 Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK; et al. (2009). "Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia". J Am Dent Assoc. 140 (10): 1238–44. PMC 2770162. PMID 19797553.
  7. 7.0 7.1 Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T; et al. (2000). "Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis". Clin Infect Dis. 30 (4): 633–8. doi:10.1086/313753. PMID 10770721.
  8. 8.0 8.1 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources